Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Sanofi-Aventis Seeks China Partnerships, Not a Research Center

publication date: Apr 4, 2008

Unlike its big pharma peers, Sanofi-Aventis will not build a research center in China. Instead, the company will seek to establish half a dozen research partnerships with China universities and state-sponsored research institutions. Potential targets mentioned for the research were cancer and rheumatoid arthritis. Dr. Marc Cuzel, head of R&D for Sanofi-Aventis, said that the advantage of working with existing institutions is the innovation that is already there. More details...

Stock Symbol: (NYSE: SNY)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital